Patient Blood Management for Neonates and Children Undergoing Cardiac Surgery: 2019 NATA Guidelines

David Faraoni1, Jens Meier2, Helen V New3

  • 1Division of Cardiac Anesthesia, Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Canada.

Insights

Patient blood management (PBM) is crucial for pediatric cardiac surgery to reduce bleeding and blood product use. Specific guidelines are needed for children, as current evidence is limited, to improve patient outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Hematology
  • Pediatric Critical Care

Background:

  • Pediatric cardiac surgery carries a high risk of bleeding, often necessitating allogeneic blood transfusions.
  • Existing patient blood management (PBM) guidelines primarily focus on adults, with limited specific evidence for pediatric cardiac surgery.
  • A gap exists in dedicated guidelines for implementing PBM in neonates and children undergoing cardiac procedures.

Purpose of the Study:

  • To develop evidence-based recommendations for anemia management and blood transfusion practices in pediatric cardiac surgery.
  • To address the lack of specific guidelines for PBM in this vulnerable patient population.
  • To identify research gaps in pediatric cardiac PBM.

Main Methods:

  • A task force from the Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis (NATA) was convened.
  • The task force aimed to synthesize existing evidence and provide expert recommendations.
  • Focus on perioperative care of neonates and children undergoing cardiac surgery.

Main Results:

  • Current evidence for PBM implementation in pediatric cardiac surgery is mainly from systematic reviews.
  • Specific, comprehensive guidelines for this population are currently unavailable.
  • The need for optimized hemoglobin, reduced blood sampling, improved hemostasis, and blood-sparing techniques is highlighted.

Conclusions:

  • Evidence-based recommendations are needed to guide PBM in pediatric cardiac surgery.
  • Implementing PBM strategies can potentially reduce allogeneic blood product administration.
  • Further research is essential to refine PBM protocols for neonates and children undergoing cardiac surgery.

Related Concept Videos

Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
841
SI Units: 2019 Redefinition01:13

SI Units: 2019 Redefinition

Measurement is an indispensable part of analytical chemistry. The result of measurement helps quantify a substance's physical property and compare it with the physical property of another substance. Each measurement comprises two components - a number indicating the magnitude and a unit of measurement as a standard for comparison. Further, the same quantity can be measured using different units of measurement, which leads to differences in magnitude.
A standard set of units has been defined...
3.4K
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
695
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
825